Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alkermes (ALKS) Other Accumulated Expenses (2016 - 2025)

Alkermes (ALKS) has disclosed Other Accumulated Expenses for 15 consecutive years, with $99.2 million as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses rose 44.26% to $99.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $99.2 million through Dec 2025, up 44.26% year-over-year, with the annual reading at $99.2 million for FY2025, 44.26% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $99.2 million at Alkermes, up from $79.8 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $117.1 million in Q3 2022, with the low at $62.5 million in Q1 2021.
  • Average Other Accumulated Expenses over 5 years is $87.8 million, with a median of $89.2 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 88.66% in 2021, then decreased 25.12% in 2024.
  • Over 5 years, Other Accumulated Expenses stood at $75.5 million in 2021, then skyrocketed by 43.23% to $108.2 million in 2022, then dropped by 15.12% to $91.8 million in 2023, then fell by 25.12% to $68.7 million in 2024, then skyrocketed by 44.26% to $99.2 million in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $99.2 million, $79.8 million, and $90.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.